Trademark Overview
On Wednesday, January 29, 2025, a trademark application was filed for KRONOSCAN with the United States Patent and Trademark Office. The USPTO has given the KRONOSCAN trademark a serial number of 79419090. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Tuesday, February 17, 2026. This trademark is owned by Prothea Technologies Ltd. The KRONOSCAN trademark is filed in the Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical devices for use in treating or diagnosing lung cancer; medical apparatus, namely, microendoscopes, spectroscopes, fluorescence spectrometer, fluorescence-based diagnostic imager, laser ablation catheter; medical devices for use in diagnosing cancer; medical apparatus and instruments for the treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for use in diagnosing lung cancer; medical testing kits for diagnosing lung cancer; oncology instruments for medical use in treatment of lung cancer; apparatus for applying laser radiation for medical purposes; diagnostic imaging apparatus for medical use; apparatus for analyzing images for medical use; parts and fittings for all of the aforesaid goods
Medical services; medical services relating to cancer; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review, counselling, and patient networking; consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review; computer information services, namely, providing information on cancer and other diseases, oncology and disease management via a global computer network; medical services, namely, medical diagnostic testing, monitoring and reporting services; information, consultancy and advisory services relating to the aforesaid services.
Scientific services, namely, processing of fluorescent images; technological services, namely, processing of fluorescent images; scientific research; technological research in the field of fluorescence-based imaging; scientific and technological services, namely, research and design in the field of fluorescence-based imaging; medical research services; scientific research in the field of oncology; conducting and directing medical and scientific research in the field of cancer prevention, causes, symptoms, diagnosis, detection, treatment and prevention; design and development of image processing software; design and development of computer software for use with medical technology; electronic scanning of images; platform as a service (PaaS) featuring software platforms for transmission of images; information, consultancy and advisory services relating to the aforesaid services
